FENGYUAN PHARMACEUTICAL(000153.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
FENGYUAN PHARMACEUTICAL
000153.SZ
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd.
2.788 T
000153.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking162/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE4.63%C
    • Profit Margin2.62%C
    • Gross Margin22.90%D
  • Growth ScoreD
    • Revenue YoY-8.56%D
    • Net Profit YoY-35.20%D
    • Total Assets YoY12.03%B
    • Net Assets YoY5.47%C
  • Cash ScoreC
    • Cash Flow Margin118.15%C
    • OCF YoY-8.56%D
  • Operating ScoreB
    • Turnover0.74B
  • Debt ScoreD
    • Gearing Ratio58.98%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

    MorningStar·
    MorningStar·

    Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

    fidelity·
    fidelity·

    FENGYUAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 100 million yuan, a year-on-year decrease of 31.92%

    Zhitong·
    SZ
    000153
    -1.62%
    Zhitong·
    SZ
    000153
    -1.62%

    Zhitong A-share lock-up release overview | October 13

    Zhitong·
    SZ
    000758
    -0.57%
    SZ
    001872
    +0.09%
    SZ
    000153
    -1.62%
    Zhitong·
    SZ
    000758
    -0.57%
    SZ
    001872
    +0.09%
    SZ
    000153
    -1.62%

    FENGYUAN PHARMACEUTICAL: The transfer of part of the company's shares by the controlling shareholder and its concerted parties has been completed

    Zhitong·
    SZ
    000153
    -1.62%
    Zhitong·
    SZ
    000153
    -1.62%
    © 2026 Longbridge｜Disclaimer